Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide vs BIAsp30 in Newly Diagnosed T2D Remission
NCT03018665Phase 4Unknown
- Sponsor
- The First Hospital of Jilin University
- Start
- Feb 2017
- Primary completion
- Dec 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by The First Hospital of Jilin University. Status: unknown.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03018665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03018665.